Valley Brook Capital Group Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.9% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,149 shares of the healthcare conglomerate’s stock after selling 135 shares during the period. UnitedHealth Group accounts for approximately 3.0% of Valley Brook Capital Group Inc.’s portfolio, making the stock its 5th largest holding. Valley Brook Capital Group Inc.’s holdings in UnitedHealth Group were worth $4,180,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Jmac Enterprises LLC raised its position in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after buying an additional 18 shares in the last quarter. Castle Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 2.0% during the 3rd quarter. Castle Wealth Management LLC now owns 2,104 shares of the healthcare conglomerate’s stock valued at $1,230,000 after purchasing an additional 41 shares during the last quarter. Deseret Mutual Benefit Administrators increased its holdings in shares of UnitedHealth Group by 2.8% in the third quarter. Deseret Mutual Benefit Administrators now owns 1,002 shares of the healthcare conglomerate’s stock worth $586,000 after buying an additional 27 shares during the period. Principal Financial Group Inc. grew its position in UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. Finally, Montecito Bank & Trust boosted its position in UnitedHealth Group by 30.8% during the 3rd quarter. Montecito Bank & Trust now owns 3,041 shares of the healthcare conglomerate’s stock valued at $1,778,000 after buying an additional 716 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Performance
NYSE:UNH traded up $4.85 during trading hours on Thursday, reaching $601.54. The company had a trading volume of 421,394 shares, compared to its average volume of 3,883,911. The firm has a market cap of $555.47 billion, a price-to-earnings ratio of 38.87, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average price is $581.13 and its 200-day moving average price is $543.74.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
Analyst Ratings Changes
Several equities research analysts have recently commented on UNH shares. Stephens dropped their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald upped their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Finally, Truist Financial reissued a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $615.53.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Market Cap Calculator: How to Calculate Market Cap
- Breakout Alert: Qualcomm Just Hit The Rally Button
- How Can Investors Benefit From After-Hours Trading
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- How to Buy Cheap Stocks Step by Step
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.